Gastrointestinal pancreatic neuroendocrine neoplasia (GEP-NEN) biomarkers and substances, systems and kits for detecting them, and related GEP-NEN diagnosis, prognosis and prediction methods and uses thereof, such as therapeutic efficacy and other results The use of detecting, predicting, stepping, profiling, classifying, and monitoring is disclosed.
展开▼
